These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22832527)

  • 21. Rare NRXN1 promoter variants in patients with schizophrenia.
    Shah AK; Tioleco NM; Nolan K; Locker J; Groh K; Villa C; Stopkova P; Pedrosa E; Lachman HM
    Neurosci Lett; 2010 May; 475(2):80-4. PubMed ID: 20347009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association study between the neurexin-1 gene and tardive dyskinesia.
    Lanning R; Lett TA; Tiwari AK; Brandl EJ; de Luca V; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Remington G; Kennedy JL; Zai CC
    Hum Psychopharmacol; 2017 Jan; 32(1):. PubMed ID: 28120489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incomplete penetrance of NRXN1 deletions in families with schizophrenia.
    Todarello G; Feng N; Kolachana BS; Li C; Vakkalanka R; Bertolino A; Weinberger DR; Straub RE
    Schizophr Res; 2014 May; 155(1-3):1-7. PubMed ID: 24680031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.
    Pak C; Danko T; Zhang Y; Aoto J; Anderson G; Maxeiner S; Yi F; Wernig M; Südhof TC
    Cell Stem Cell; 2015 Sep; 17(3):316-28. PubMed ID: 26279266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility.
    Suárez-Rama JJ; Arrojo M; Sobrino B; Amigo J; Brenlla J; Agra S; Paz E; Brión M; Carracedo Á; Páramo M; Costas J
    J Psychiatr Res; 2015; 66-67():38-44. PubMed ID: 25943950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived
    Pak C; Danko T; Mirabella VR; Wang J; Liu Y; Vangipuram M; Grieder S; Zhang X; Ward T; Huang YA; Jin K; Dexheimer P; Bardes E; Mitelpunkt A; Ma J; McLachlan M; Moore JC; Qu P; Purmann C; Dage JL; Swanson BJ; Urban AE; Aronow BJ; Pang ZP; Levinson DF; Wernig M; Südhof TC
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34035170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptome-wide analysis of TDP-43 binding small RNAs identifies miR-NID1 (miR-8485), a novel miRNA that represses NRXN1 expression.
    Fan Z; Chen X; Chen R
    Genomics; 2014 Jan; 103(1):76-82. PubMed ID: 23827811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.
    Lipina TV; Kaidanovich-Beilin O; Patel S; Wang M; Clapcote SJ; Liu F; Woodgett JR; Roder JC
    Synapse; 2011 Mar; 65(3):234-48. PubMed ID: 20687111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mini-review: Update on the genetics of schizophrenia.
    Coelewij L; Curtis D
    Ann Hum Genet; 2018 Sep; 82(5):239-243. PubMed ID: 29923609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions.
    Schaaf CP; Boone PM; Sampath S; Williams C; Bader PI; Mueller JM; Shchelochkov OA; Brown CW; Crawford HP; Phalen JA; Tartaglia NR; Evans P; Campbell WM; Tsai AC; Parsley L; Grayson SW; Scheuerle A; Luzzi CD; Thomas SK; Eng PA; Kang SH; Patel A; Stankiewicz P; Cheung SW
    Eur J Hum Genet; 2012 Dec; 20(12):1240-7. PubMed ID: 22617343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perinatal exposure to bisphenol-A impairs spatial memory through upregulation of neurexin1 and neuroligin3 expression in male mouse brain.
    Kumar D; Thakur MK
    PLoS One; 2014; 9(10):e110482. PubMed ID: 25330104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide analysis of the mouse lung transcriptome reveals novel molecular gene interaction networks and cell-specific expression signatures.
    Alberts R; Lu L; Williams RW; Schughart K
    Respir Res; 2011 May; 12(1):61. PubMed ID: 21535883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diurnal rhythms in neurexins transcripts and inhibitory/excitatory synapse scaffold proteins in the biological clock.
    Shapiro-Reznik M; Jilg A; Lerner H; Earnest DJ; Zisapel N
    PLoS One; 2012; 7(5):e37894. PubMed ID: 22662246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterozygous deletion of α-neurexin I or α-neurexin II results in behaviors relevant to autism and schizophrenia.
    Dachtler J; Ivorra JL; Rowland TE; Lever C; Rodgers RJ; Clapcote SJ
    Behav Neurosci; 2015 Dec; 129(6):765-76. PubMed ID: 26595880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation analysis of the NRXN1 gene in a Chinese autism cohort.
    Liu Y; Hu Z; Xun G; Peng Y; Lu L; Xu X; Xiong Z; Xia L; Liu D; Li W; Zhao J; Xia K
    J Psychiatr Res; 2012 May; 46(5):630-4. PubMed ID: 22405623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
    Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N
    J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
    O'Dushlaine C; Kenny E; Heron E; Donohoe G; Gill M; Morris D; ; Corvin A
    Mol Psychiatry; 2011 Mar; 16(3):286-92. PubMed ID: 20157312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related expression of Neurexin1 and Neuroligin3 is correlated with presynaptic density in the cerebral cortex and hippocampus of male mice.
    Kumar D; Thakur MK
    Age (Dordr); 2015; 37(2):17. PubMed ID: 25693924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single cell analysis of autism patient with bi-allelic NRXN1-alpha deletion reveals skewed fate choice in neural progenitors and impaired neuronal functionality.
    Lam M; Moslem M; Bryois J; Pronk RJ; Uhlin E; Ellström ID; Laan L; Olive J; Morse R; Rönnholm H; Louhivuori L; Korol SV; Dahl N; Uhlén P; Anderlid BM; Kele M; Sullivan PF; Falk A
    Exp Cell Res; 2019 Oct; 383(1):111469. PubMed ID: 31302032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders.
    Duong L; Klitten LL; Møller RS; Ingason A; Jakobsen KD; Skjødt C; Didriksen M; Hjalgrim H; Werge T; Tommerup N
    Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):354-8. PubMed ID: 22337556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.